Anti-Peptic Ulcer Drugs Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product ( Proton Pump Inhibitors (PPIs), Potassium-Competitive Acid Blockers (P-CAB), Antacids, H2 Antagonists, Ulcer Protective Drugs ); Application ( Gastritis, Gastric Ulcers, Duodenal Ulcers, Gastroesophageal Reflux Disease (GERD) )
Report Code: TIPRE00010954 No. of Pages: 150 Category: Pharmaceuticals Status: Upcoming
MARKET INTRODUCTION
Antiulcer agents and medications for acid peptic disease are commonly used drugs that rarely cause liver injury. Both classes of antiulcer medications block the pathways of acid production or secretion, decreasing gastric acidity, improving symptoms and aiding in healing of acid-peptic diseases. The most common remedy is a combination of antibiotic drugs to kill the H. pylori bacteria and medications to get rid of acid in your stomach. These typically include proton pump inhibitors (like Aciphex or Nexium), and antibiotics.
MARKET DYNAMICS
The anti-peptic ulcer drugs market is driving due to the growing prevalence of chronic diseases and cancer and the increasing demand for cell therapies for the treatment of these diseases. growth during the forecast period. Moreover, the rising preference of patients to consume drugs instead of surgical procedure is driving the market growth in the forecast period.
MARKET SCOPE
The "Anti-Peptic Ulcer Drugs Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of anti-peptic ulcer drugs market with detailed market segmentation by product, and application. The anti-peptic ulcer drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in anti-peptic ulcer drugs market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The anti-peptic ulcer drugs market is segmented on the basis of product and application. Based on product, the market is segmented as proton pump inhibitors (PPIs), potassium-competitive acid blockers (P-CAB), antacids, h2 antagonists and ulcer protective drugs. On the basis of application, the market is categorized as gastritis, gastric ulcers, duodenal ulcers and gastroesophageal reflux disease (GERD).
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the anti-peptic ulcer drugs market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The anti-peptic ulcer drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting anti peptic ulcer drugs market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the anti-peptic ulcer drugs market in these regions.
The report covers key developments in the anti -peptic ulcer drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from anti peptic ulcer drugs market are anticipated to have lucrative growth opportunities in the future with the rising demand for anti-peptic ulcer drugs in the global market. Below mentioned is the list of few companies engaged in the anti-peptic ulcer drugs market.
The report also includes the profiles of key players in anti-peptic ulcer drugs market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Antiulcer agents and medications for acid peptic disease are commonly used drugs that rarely cause liver injury. Both classes of antiulcer medications block the pathways of acid production or secretion, decreasing gastric acidity, improving symptoms and aiding in healing of acid-peptic diseases. The most common remedy is a combination of antibiotic drugs to kill the H. pylori bacteria and medications to get rid of acid in your stomach. These typically include proton pump inhibitors (like Aciphex or Nexium), and antibiotics.
MARKET DYNAMICS
The anti-peptic ulcer drugs market is driving due to the growing prevalence of chronic diseases and cancer and the increasing demand for cell therapies for the treatment of these diseases. growth during the forecast period. Moreover, the rising preference of patients to consume drugs instead of surgical procedure is driving the market growth in the forecast period.
MARKET SCOPE
The "Anti-Peptic Ulcer Drugs Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of anti-peptic ulcer drugs market with detailed market segmentation by product, and application. The anti-peptic ulcer drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in anti-peptic ulcer drugs market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The anti-peptic ulcer drugs market is segmented on the basis of product and application. Based on product, the market is segmented as proton pump inhibitors (PPIs), potassium-competitive acid blockers (P-CAB), antacids, h2 antagonists and ulcer protective drugs. On the basis of application, the market is categorized as gastritis, gastric ulcers, duodenal ulcers and gastroesophageal reflux disease (GERD).
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the anti-peptic ulcer drugs market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The anti-peptic ulcer drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting anti peptic ulcer drugs market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the anti-peptic ulcer drugs market in these regions.
The report covers key developments in the anti -peptic ulcer drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from anti peptic ulcer drugs market are anticipated to have lucrative growth opportunities in the future with the rising demand for anti-peptic ulcer drugs in the global market. Below mentioned is the list of few companies engaged in the anti-peptic ulcer drugs market.
The report also includes the profiles of key players in anti-peptic ulcer drugs market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- AstraZeneca
- Ask-pharm
- Takeda
- Yangtze River Pharm
- Shandong Luoxin
- HUADONG MEDICINE CO.,LTD
- Changzhou Siyao
- Beijing Yuekang
- Guangdong Dahua
- Xian Janssen
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Anti Peptic Ulcer Drugs Market - By Product
1.3.2 Anti Peptic Ulcer Drugs Market - By Application
1.3.3 Anti Peptic Ulcer Drugs Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ANTI PEPTIC ULCER DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ANTI PEPTIC ULCER DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ANTI PEPTIC ULCER DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. ANTI PEPTIC ULCER DRUGS - GLOBAL MARKET OVERVIEW
6.2. ANTI PEPTIC ULCER DRUGS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. ANTI PEPTIC ULCER DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. PROTON PUMP INHIBITORS (PPIS)
7.3.1. Overview
7.3.2. Proton Pump Inhibitors (PPIs) Market Forecast and Analysis
7.4. POTASSIUM-COMPETITIVE ACID BLOCKERS (P-CAB)
7.4.1. Overview
7.4.2. Potassium-Competitive Acid Blockers (P-CAB) Market Forecast and Analysis
7.5. ANTACIDS
7.5.1. Overview
7.5.2. Antacids Market Forecast and Analysis
7.6. H2 ANTAGONISTS
7.6.1. Overview
7.6.2. H2 Antagonists Market Forecast and Analysis
7.7. ULCER PROTECTIVE DRUGS
7.7.1. Overview
7.7.2. Ulcer Protective Drugs Market Forecast and Analysis
8. ANTI PEPTIC ULCER DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. GASTRITIS
8.3.1. Overview
8.3.2. Gastritis Market Forecast and Analysis
8.4. GASTRIC ULCERS
8.4.1. Overview
8.4.2. Gastric Ulcers Market Forecast and Analysis
8.5. DUODENAL ULCERS
8.5.1. Overview
8.5.2. Duodenal Ulcers Market Forecast and Analysis
8.6. GASTROESOPHAGEAL REFLUX DISEASE (GERD)
8.6.1. Overview
8.6.2. Gastroesophageal Reflux Disease (GERD) Market Forecast and Analysis
9. ANTI PEPTIC ULCER DRUGS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Anti Peptic Ulcer Drugs Market Overview
9.1.2 North America Anti Peptic Ulcer Drugs Market Forecasts and Analysis
9.1.3 North America Anti Peptic Ulcer Drugs Market Forecasts and Analysis - By Product
9.1.4 North America Anti Peptic Ulcer Drugs Market Forecasts and Analysis - By Application
9.1.5 North America Anti Peptic Ulcer Drugs Market Forecasts and Analysis - By Countries
9.1.5.1 United States Anti Peptic Ulcer Drugs Market
9.1.5.1.1 United States Anti Peptic Ulcer Drugs Market by Product
9.1.5.1.2 United States Anti Peptic Ulcer Drugs Market by Application
9.1.5.2 Canada Anti Peptic Ulcer Drugs Market
9.1.5.2.1 Canada Anti Peptic Ulcer Drugs Market by Product
9.1.5.2.2 Canada Anti Peptic Ulcer Drugs Market by Application
9.1.5.3 Mexico Anti Peptic Ulcer Drugs Market
9.1.5.3.1 Mexico Anti Peptic Ulcer Drugs Market by Product
9.1.5.3.2 Mexico Anti Peptic Ulcer Drugs Market by Application
9.2. EUROPE
9.2.1 Europe Anti Peptic Ulcer Drugs Market Overview
9.2.2 Europe Anti Peptic Ulcer Drugs Market Forecasts and Analysis
9.2.3 Europe Anti Peptic Ulcer Drugs Market Forecasts and Analysis - By Product
9.2.4 Europe Anti Peptic Ulcer Drugs Market Forecasts and Analysis - By Application
9.2.5 Europe Anti Peptic Ulcer Drugs Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Anti Peptic Ulcer Drugs Market
9.2.5.1.1 Germany Anti Peptic Ulcer Drugs Market by Product
9.2.5.1.2 Germany Anti Peptic Ulcer Drugs Market by Application
9.2.5.2 France Anti Peptic Ulcer Drugs Market
9.2.5.2.1 France Anti Peptic Ulcer Drugs Market by Product
9.2.5.2.2 France Anti Peptic Ulcer Drugs Market by Application
9.2.5.3 Italy Anti Peptic Ulcer Drugs Market
9.2.5.3.1 Italy Anti Peptic Ulcer Drugs Market by Product
9.2.5.3.2 Italy Anti Peptic Ulcer Drugs Market by Application
9.2.5.4 Spain Anti Peptic Ulcer Drugs Market
9.2.5.4.1 Spain Anti Peptic Ulcer Drugs Market by Product
9.2.5.4.2 Spain Anti Peptic Ulcer Drugs Market by Application
9.2.5.5 United Kingdom Anti Peptic Ulcer Drugs Market
9.2.5.5.1 United Kingdom Anti Peptic Ulcer Drugs Market by Product
9.2.5.5.2 United Kingdom Anti Peptic Ulcer Drugs Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Anti Peptic Ulcer Drugs Market Overview
9.3.2 Asia-Pacific Anti Peptic Ulcer Drugs Market Forecasts and Analysis
9.3.3 Asia-Pacific Anti Peptic Ulcer Drugs Market Forecasts and Analysis - By Product
9.3.4 Asia-Pacific Anti Peptic Ulcer Drugs Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Anti Peptic Ulcer Drugs Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Anti Peptic Ulcer Drugs Market
9.3.5.1.1 Australia Anti Peptic Ulcer Drugs Market by Product
9.3.5.1.2 Australia Anti Peptic Ulcer Drugs Market by Application
9.3.5.2 China Anti Peptic Ulcer Drugs Market
9.3.5.2.1 China Anti Peptic Ulcer Drugs Market by Product
9.3.5.2.2 China Anti Peptic Ulcer Drugs Market by Application
9.3.5.3 India Anti Peptic Ulcer Drugs Market
9.3.5.3.1 India Anti Peptic Ulcer Drugs Market by Product
9.3.5.3.2 India Anti Peptic Ulcer Drugs Market by Application
9.3.5.4 Japan Anti Peptic Ulcer Drugs Market
9.3.5.4.1 Japan Anti Peptic Ulcer Drugs Market by Product
9.3.5.4.2 Japan Anti Peptic Ulcer Drugs Market by Application
9.3.5.5 South Korea Anti Peptic Ulcer Drugs Market
9.3.5.5.1 South Korea Anti Peptic Ulcer Drugs Market by Product
9.3.5.5.2 South Korea Anti Peptic Ulcer Drugs Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Anti Peptic Ulcer Drugs Market Overview
9.4.2 Middle East and Africa Anti Peptic Ulcer Drugs Market Forecasts and Analysis
9.4.3 Middle East and Africa Anti Peptic Ulcer Drugs Market Forecasts and Analysis - By Product
9.4.4 Middle East and Africa Anti Peptic Ulcer Drugs Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Anti Peptic Ulcer Drugs Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Anti Peptic Ulcer Drugs Market
9.4.5.1.1 South Africa Anti Peptic Ulcer Drugs Market by Product
9.4.5.1.2 South Africa Anti Peptic Ulcer Drugs Market by Application
9.4.5.2 Saudi Arabia Anti Peptic Ulcer Drugs Market
9.4.5.2.1 Saudi Arabia Anti Peptic Ulcer Drugs Market by Product
9.4.5.2.2 Saudi Arabia Anti Peptic Ulcer Drugs Market by Application
9.4.5.3 U.A.E Anti Peptic Ulcer Drugs Market
9.4.5.3.1 U.A.E Anti Peptic Ulcer Drugs Market by Product
9.4.5.3.2 U.A.E Anti Peptic Ulcer Drugs Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Anti Peptic Ulcer Drugs Market Overview
9.5.2 South and Central America Anti Peptic Ulcer Drugs Market Forecasts and Analysis
9.5.3 South and Central America Anti Peptic Ulcer Drugs Market Forecasts and Analysis - By Product
9.5.4 South and Central America Anti Peptic Ulcer Drugs Market Forecasts and Analysis - By Application
9.5.5 South and Central America Anti Peptic Ulcer Drugs Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Anti Peptic Ulcer Drugs Market
9.5.5.1.1 Brazil Anti Peptic Ulcer Drugs Market by Product
9.5.5.1.2 Brazil Anti Peptic Ulcer Drugs Market by Application
9.5.5.2 Argentina Anti Peptic Ulcer Drugs Market
9.5.5.2.1 Argentina Anti Peptic Ulcer Drugs Market by Product
9.5.5.2.2 Argentina Anti Peptic Ulcer Drugs Market by Application
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL ANTI PEPTIC ULCER DRUGS MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Rest of the World
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. ANTI PEPTIC ULCER DRUGS MARKET, KEY COMPANY PROFILES
12.1. ASTRAZENECA
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ASK-PHARM
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. TAKEDA
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. YANGTZE RIVER PHARM
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. SHANDONG LUOXIN
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. HUADONG MEDICINE CO.,LTD
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. CHANGZHOU SIYAO
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. BEIJING YUEKANG
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. GUANGDONG DAHUA
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. XIAN JANSSEN
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Anti Peptic Ulcer Drugs Market - By Product
1.3.2 Anti Peptic Ulcer Drugs Market - By Application
1.3.3 Anti Peptic Ulcer Drugs Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ANTI PEPTIC ULCER DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ANTI PEPTIC ULCER DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ANTI PEPTIC ULCER DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. ANTI PEPTIC ULCER DRUGS - GLOBAL MARKET OVERVIEW
6.2. ANTI PEPTIC ULCER DRUGS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. ANTI PEPTIC ULCER DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. PROTON PUMP INHIBITORS (PPIS)
7.3.1. Overview
7.3.2. Proton Pump Inhibitors (PPIs) Market Forecast and Analysis
7.4. POTASSIUM-COMPETITIVE ACID BLOCKERS (P-CAB)
7.4.1. Overview
7.4.2. Potassium-Competitive Acid Blockers (P-CAB) Market Forecast and Analysis
7.5. ANTACIDS
7.5.1. Overview
7.5.2. Antacids Market Forecast and Analysis
7.6. H2 ANTAGONISTS
7.6.1. Overview
7.6.2. H2 Antagonists Market Forecast and Analysis
7.7. ULCER PROTECTIVE DRUGS
7.7.1. Overview
7.7.2. Ulcer Protective Drugs Market Forecast and Analysis
8. ANTI PEPTIC ULCER DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. GASTRITIS
8.3.1. Overview
8.3.2. Gastritis Market Forecast and Analysis
8.4. GASTRIC ULCERS
8.4.1. Overview
8.4.2. Gastric Ulcers Market Forecast and Analysis
8.5. DUODENAL ULCERS
8.5.1. Overview
8.5.2. Duodenal Ulcers Market Forecast and Analysis
8.6. GASTROESOPHAGEAL REFLUX DISEASE (GERD)
8.6.1. Overview
8.6.2. Gastroesophageal Reflux Disease (GERD) Market Forecast and Analysis
9. ANTI PEPTIC ULCER DRUGS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Anti Peptic Ulcer Drugs Market Overview
9.1.2 North America Anti Peptic Ulcer Drugs Market Forecasts and Analysis
9.1.3 North America Anti Peptic Ulcer Drugs Market Forecasts and Analysis - By Product
9.1.4 North America Anti Peptic Ulcer Drugs Market Forecasts and Analysis - By Application
9.1.5 North America Anti Peptic Ulcer Drugs Market Forecasts and Analysis - By Countries
9.1.5.1 United States Anti Peptic Ulcer Drugs Market
9.1.5.1.1 United States Anti Peptic Ulcer Drugs Market by Product
9.1.5.1.2 United States Anti Peptic Ulcer Drugs Market by Application
9.1.5.2 Canada Anti Peptic Ulcer Drugs Market
9.1.5.2.1 Canada Anti Peptic Ulcer Drugs Market by Product
9.1.5.2.2 Canada Anti Peptic Ulcer Drugs Market by Application
9.1.5.3 Mexico Anti Peptic Ulcer Drugs Market
9.1.5.3.1 Mexico Anti Peptic Ulcer Drugs Market by Product
9.1.5.3.2 Mexico Anti Peptic Ulcer Drugs Market by Application
9.2. EUROPE
9.2.1 Europe Anti Peptic Ulcer Drugs Market Overview
9.2.2 Europe Anti Peptic Ulcer Drugs Market Forecasts and Analysis
9.2.3 Europe Anti Peptic Ulcer Drugs Market Forecasts and Analysis - By Product
9.2.4 Europe Anti Peptic Ulcer Drugs Market Forecasts and Analysis - By Application
9.2.5 Europe Anti Peptic Ulcer Drugs Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Anti Peptic Ulcer Drugs Market
9.2.5.1.1 Germany Anti Peptic Ulcer Drugs Market by Product
9.2.5.1.2 Germany Anti Peptic Ulcer Drugs Market by Application
9.2.5.2 France Anti Peptic Ulcer Drugs Market
9.2.5.2.1 France Anti Peptic Ulcer Drugs Market by Product
9.2.5.2.2 France Anti Peptic Ulcer Drugs Market by Application
9.2.5.3 Italy Anti Peptic Ulcer Drugs Market
9.2.5.3.1 Italy Anti Peptic Ulcer Drugs Market by Product
9.2.5.3.2 Italy Anti Peptic Ulcer Drugs Market by Application
9.2.5.4 Spain Anti Peptic Ulcer Drugs Market
9.2.5.4.1 Spain Anti Peptic Ulcer Drugs Market by Product
9.2.5.4.2 Spain Anti Peptic Ulcer Drugs Market by Application
9.2.5.5 United Kingdom Anti Peptic Ulcer Drugs Market
9.2.5.5.1 United Kingdom Anti Peptic Ulcer Drugs Market by Product
9.2.5.5.2 United Kingdom Anti Peptic Ulcer Drugs Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Anti Peptic Ulcer Drugs Market Overview
9.3.2 Asia-Pacific Anti Peptic Ulcer Drugs Market Forecasts and Analysis
9.3.3 Asia-Pacific Anti Peptic Ulcer Drugs Market Forecasts and Analysis - By Product
9.3.4 Asia-Pacific Anti Peptic Ulcer Drugs Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Anti Peptic Ulcer Drugs Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Anti Peptic Ulcer Drugs Market
9.3.5.1.1 Australia Anti Peptic Ulcer Drugs Market by Product
9.3.5.1.2 Australia Anti Peptic Ulcer Drugs Market by Application
9.3.5.2 China Anti Peptic Ulcer Drugs Market
9.3.5.2.1 China Anti Peptic Ulcer Drugs Market by Product
9.3.5.2.2 China Anti Peptic Ulcer Drugs Market by Application
9.3.5.3 India Anti Peptic Ulcer Drugs Market
9.3.5.3.1 India Anti Peptic Ulcer Drugs Market by Product
9.3.5.3.2 India Anti Peptic Ulcer Drugs Market by Application
9.3.5.4 Japan Anti Peptic Ulcer Drugs Market
9.3.5.4.1 Japan Anti Peptic Ulcer Drugs Market by Product
9.3.5.4.2 Japan Anti Peptic Ulcer Drugs Market by Application
9.3.5.5 South Korea Anti Peptic Ulcer Drugs Market
9.3.5.5.1 South Korea Anti Peptic Ulcer Drugs Market by Product
9.3.5.5.2 South Korea Anti Peptic Ulcer Drugs Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Anti Peptic Ulcer Drugs Market Overview
9.4.2 Middle East and Africa Anti Peptic Ulcer Drugs Market Forecasts and Analysis
9.4.3 Middle East and Africa Anti Peptic Ulcer Drugs Market Forecasts and Analysis - By Product
9.4.4 Middle East and Africa Anti Peptic Ulcer Drugs Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Anti Peptic Ulcer Drugs Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Anti Peptic Ulcer Drugs Market
9.4.5.1.1 South Africa Anti Peptic Ulcer Drugs Market by Product
9.4.5.1.2 South Africa Anti Peptic Ulcer Drugs Market by Application
9.4.5.2 Saudi Arabia Anti Peptic Ulcer Drugs Market
9.4.5.2.1 Saudi Arabia Anti Peptic Ulcer Drugs Market by Product
9.4.5.2.2 Saudi Arabia Anti Peptic Ulcer Drugs Market by Application
9.4.5.3 U.A.E Anti Peptic Ulcer Drugs Market
9.4.5.3.1 U.A.E Anti Peptic Ulcer Drugs Market by Product
9.4.5.3.2 U.A.E Anti Peptic Ulcer Drugs Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Anti Peptic Ulcer Drugs Market Overview
9.5.2 South and Central America Anti Peptic Ulcer Drugs Market Forecasts and Analysis
9.5.3 South and Central America Anti Peptic Ulcer Drugs Market Forecasts and Analysis - By Product
9.5.4 South and Central America Anti Peptic Ulcer Drugs Market Forecasts and Analysis - By Application
9.5.5 South and Central America Anti Peptic Ulcer Drugs Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Anti Peptic Ulcer Drugs Market
9.5.5.1.1 Brazil Anti Peptic Ulcer Drugs Market by Product
9.5.5.1.2 Brazil Anti Peptic Ulcer Drugs Market by Application
9.5.5.2 Argentina Anti Peptic Ulcer Drugs Market
9.5.5.2.1 Argentina Anti Peptic Ulcer Drugs Market by Product
9.5.5.2.2 Argentina Anti Peptic Ulcer Drugs Market by Application
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL ANTI PEPTIC ULCER DRUGS MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Rest of the World
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. ANTI PEPTIC ULCER DRUGS MARKET, KEY COMPANY PROFILES
12.1. ASTRAZENECA
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ASK-PHARM
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. TAKEDA
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. YANGTZE RIVER PHARM
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. SHANDONG LUOXIN
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. HUADONG MEDICINE CO.,LTD
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. CHANGZHOU SIYAO
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. BEIJING YUEKANG
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. GUANGDONG DAHUA
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. XIAN JANSSEN
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies
1. AstraZeneca
2. Ask-pharm
3. Takeda
4. Yangtze River Pharm
5. Shandong Luoxin
6. HUADONG MEDICINE CO.,LTD
7. Changzhou Siyao
8. Beijing Yuekang
9. Guangdong Dahua
10. Xian Janssen
1. AstraZeneca
2. Ask-pharm
3. Takeda
4. Yangtze River Pharm
5. Shandong Luoxin
6. HUADONG MEDICINE CO.,LTD
7. Changzhou Siyao
8. Beijing Yuekang
9. Guangdong Dahua
10. Xian Janssen